Business Description
Instadose Pharma Corp
NAICS : 325411
SIC : 2834
5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6
Compare
Compare
Traded in other countries / regions
INSD.USA
Description
Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 0 | |||||
| Beneish M-Score | 0 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 84.16 | |||||
| 9-Day RSI | 56.27 | |||||
| 14-Day RSI | 38.87 | |||||
| 6-1 Month Momentum % | -74.63 | |||||
| 12-1 Month Momentum % | -59.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.01 | |||||
| Quick Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -24.59 | |||||
| ROA % | -3.77 | |||||
| ROIC % | -3.39 | |||||
| ROC (Joel Greenblatt) % | -42.57 | |||||
| ROCE % | -24.15 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 9.43 | |||||
| Price-to-Free-Cash-Flow | 83.33 | |||||
| Price-to-Operating-Cash-Flow | 83.33 | |||||
| EV-to-EBIT | -198.47 | |||||
| EV-to-EBITDA | -276.95 | |||||
| EV-to-FCF | 468.62 | |||||
| Earnings Yield (Greenblatt) % | -0.5 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with OTCPK:INSD
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0 | ||
| EPS (TTM) ($) | -0.013 | ||
| Beta | 0 | ||
| Volatility % | 318.22 | ||
| 14-Day RSI | 38.87 | ||
| 14-Day ATR ($) | 0.074059 | ||
| 20-Day SMA ($) | 0.26715 | ||
| 12-1 Month Momentum % | -59.4 | ||
| 52-Week Range ($) | 0.0003 - 60 | ||
| Shares Outstanding (Mil) | 531.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Instadose Pharma Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||